CN103007241A - Medicament for treating silicosis - Google Patents
Medicament for treating silicosis Download PDFInfo
- Publication number
- CN103007241A CN103007241A CN2013100003611A CN201310000361A CN103007241A CN 103007241 A CN103007241 A CN 103007241A CN 2013100003611 A CN2013100003611 A CN 2013100003611A CN 201310000361 A CN201310000361 A CN 201310000361A CN 103007241 A CN103007241 A CN 103007241A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicament
- herba
- silicosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating silicosis, which is prepared from the following bulk pharmaceutical components in parts by weight: 4-8 parts of dried gingers, 6-10 parts of rabdosia rubescens, 1-5 parts of licorice roots, 1-3 parts of euphorbia kansui, 1-5 parts of eucommia barks, 3-6 parts of astragalus roots, 1-5 parts of solidago virgaurea, 10-15 parts of divaricate saposhnikovia roots, 3-7 parts of indian trum etflower seeds, 10-20 parts of rhizoma ligustici wallichii, 3-6 parts of radix stemonae, 10-15 parts of herba orostachyos, 4-8 parts of radix sophorae flavescentis, 1-5 parts of cortex moutan, 1-3 parts of radix ophiopogonis and 3-7 parts of asarum. The medicament for treating silicosis disclosed by the invention is simple in prescription, low in price, clear in curative effect, strong in patient adaptability, and suitable for clinical large-scale promotion.
Description
Technical field
The present invention relates to the Respiratory Medicine field, specifically, relate to a kind of medicament for the treatment of anthraco-silicosis.
Background technology
Anthraco-silicosis is because long-term suction contains the caused pneumoconiosis of rock dirt of crystal type free silicon dioxide in a large number.The silicotic generally in early days can be asymptomatic or symptom is not obvious, and along with pathological development, symptom increases, and main manifestations is as follows: (one) cough, expectoration are coughed owing to dust stimulation and respiratory inflammation, or the reflex cough is arranged.Degree and what of amount of expectoration of cough are closely related with bronchitis or pulmonary's secondary infection, but with pneumosilicosis lesion degree and inconsistent.Small number of patients can have bloody sputum.If any repeatedly spitting blood in a large number, then should consider to merge tuberculosis or bronchiectasis.(2) chest pain 40%～60% patient has acupuncture sample chest pain.Multidigit is in the one or both sides of middle and upper part, shirtfront, and is irrelevant with breathing, position and work, is everlasting overcast and rainy and occurs during climate variability.(3) degree uncomfortable in chest, out of breath is relevant with extent of disease and character.Pathological changes is extensively fast with progress, and is then out of breath obvious, and the aggravation of carrying out property.This is because the extensive fibrosis of lung tissue, the alveolar considerable damage, and bronchial stenosis and pleural thickening and adhesion cause ventilating and the result of ventilatory infringement.Patient Shang Ke has giddy, weak, cardiopalmus, stomach poor appetite the symptom such as to move back.The medicine of developing a kind of determined curative effect, convenient and practical treatment anthraco-silicosis is becoming inevitable.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of anthraco-silicosis.
In order to realize method of the present invention, the invention provides a kind of medicament for the treatment of anthraco-silicosis, it is to be made according to weight portion by following raw material medicaments: 3～7 parts of 4～8 parts of Rhizoma Zingiberiss, 6～10 parts of Rabdosia rubescens, 1～5 part in Radix Glycyrrhizae, 1～3 part of Radix Kansui, 1～5 part of the Cortex Eucommiae, 3～6 parts of the Radixs Astragali, 1～5 part of Herba Solidaginis, 10～15 parts of Radix Saposhnikoviaes, 3～7 parts of Semen Oroxylis, 10～20 parts of Rhizoma Chuanxiongs, 3～6 parts of the Radixs Stemonae, 10～15 parts of Herba Orostachyos, 4～8 parts of Radix Sophorae Flavescentiss, 1～5 part of Cortex Moutan, 1～3 part of Radix Ophiopogonis and Herba Asaris.
Preferably, the medicament for the treatment of anthraco-silicosis of the present invention is to be made according to weight portion by following raw material medicaments: 6 parts of 7 parts of Rhizoma Zingiberiss, 8 parts of Rabdosia rubescens, 3 parts in Radix Glycyrrhizae, 2 parts of Radix Kansuis, 2 parts of the Cortexs Eucommiae, 4 parts of the Radixs Astragali, 4 parts of Herba Solidaginiss, 11 parts of Radix Saposhnikoviaes, 6 parts of Semen Oroxylis, 17 parts of Rhizoma Chuanxiongs, 5 parts of the Radixs Stemonae, 13 parts of Herba Orostachyos, 7 parts of Radix Sophorae Flavescentiss, 2 parts of Cortex Moutans, 2 parts of Radix Ophiopogonis and Herba Asaris.
Preferably, described medicament is tablet, buccal tablet, instant or decoction.
The medicament prescription for the treatment of anthraco-silicosis of the present invention is simple, is common Chinese medicine, low price, and curative effect is clear and definite, and patient adaptability is strong, is suitable for clinically large-scale popularization.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
Embodiment 1
Take by weighing Rhizoma Zingiberis 70 gram, Rabdosia rubescens 80 grams, Radix Glycyrrhizae 30 grams, Radix Kansui 20 grams, the Cortex Eucommiae 20 grams, the Radix Astragali 40 grams, Herba Solidaginis 40 grams, Radix Saposhnikoviae 110 grams, Semen Oroxyli 60 grams, Rhizoma Chuanxiong 170 grams, the Radix Stemonae 50 grams, Herba Orostachyos 130 grams, Radix Sophorae Flavescentis 70 grams, Cortex Moutan 20 grams, Radix Ophiopogonis 20 gram and Herba Asari 60 grams, add 2500 milliliters of entry, in sealed container, 70 ℃ of lower heating 3 hours, be cooled to room temperature.Filter, filtrate is decoction of the present invention.
Experimental example
Diagnostic criteria
China has announced " pneumoconiosis diagnosis standard and treatment principle " in December, 1986, and wherein the X-ray Diagnosis of Pneumoconiosis standard is applicable to the legal various pneumoconiosis of country, and specific standards is as follows: 1. without the x-ray performance of pneumoconiosis (code name 0) (1) 0 without pneumoconiosis.(2) performance of 0+X line still is diagnosed as " I " person not.2. first phase pneumoconiosis (code name I).(1) I has the little shade of similar round of 1 grade of closeness, and distribution respectively has a place at least in two lung districts, and every place diameter is not less than 2cm; Or the irregular small opacities of 1 grade of closeness is arranged, its distribution is no less than two lung districts.(2) the little shade showed increased of I+, but have one still to be decided to be not " II " person in closeness and the distribution.3. the second stage of pneumoconiosis (code name II) (1) II has similar round or the irregular small opacities of 2 grades of closenesses, and distribution surpasses four lung districts; Or the little shade of 3 grades of closenesses is arranged, distribution reaches four lung districts.(2) closeness is arranged is 3 grades little shade to II+, and its distribution surpasses four lung districts; Or there is large shade still to be not " III " person.4. three phase pneumoconiosis (code name III), III has large shade to occur, and its major diameter is not less than 2cm, and wide footpath is not less than 1cm.The area of the single large shade of III+ or the summation of a plurality of large shaded areas surpass right upper lung district area person.
30 routine patients all make a definite diagnosis after diagnosing.I phases 16 example wherein, II phases 8 example, III phases 6 example.Merge pulmonary tuberculosis 10 examples; Emphysema, the lung heart 14 examples, pneumothorax 1 example.Year mean age 60.8 (51-72).The symptoms such as cough, expectoration, chest discomfort are all arranged, and 16 examples have tired, the symptoms such as gas is tight, two lower limbs edema of the different heart of degree, 4 example spitting of bloods (or sputum mixed with blood).
Use the decoction of preparation among the embodiment 1 to treat.Every day three times, each oral 300 milliliters, treated continuously 9 months.
Criterion of therapeutical effect
Produce effects: the symptoms such as cough, expectoration, the heart tire out, gas is tight obviously alleviate, and lower limbs edema disappears, and heart merit is normal.Effectively: the sx↓s such as cough, expectoration, the heart is tired, gas is tight, lower limbs edema, heart merit II-III level.Invalid: nothing changes before and after the treatment.
Therapeutic outcome
Compare before the treatment with after the treatment, wherein produce effects 25 examples account for 83.33%, and effective 5 examples account for 16.67%.Total effective rate is 100%.
Claims (3)
1. medicament for the treatment of anthraco-silicosis is characterized in that it is to be made according to weight portion by following raw material medicaments: 3～7 parts of 4～8 parts of Rhizoma Zingiberiss, 6～10 parts of Rabdosia rubescens, 1～5 part in Radix Glycyrrhizae, 1～3 part of Radix Kansui, 1～5 part of the Cortex Eucommiae, 3～6 parts of the Radixs Astragali, 1～5 part of Herba Solidaginis, 10～15 parts of Radix Saposhnikoviaes, 3～7 parts of Semen Oroxylis, 10～20 parts of Rhizoma Chuanxiongs, 3～6 parts of the Radixs Stemonae, 10～15 parts of Herba Orostachyos, 4～8 parts of Radix Sophorae Flavescentiss, 1～5 part of Cortex Moutan, 1～3 part of Radix Ophiopogonis and Herba Asaris.
2. the medicament for the treatment of anthraco-silicosis according to claim 1 is characterized in that it is to be made according to weight portion by following raw material medicaments: 6 parts of 7 parts of Rhizoma Zingiberiss, 8 parts of Rabdosia rubescens, 3 parts in Radix Glycyrrhizae, 2 parts of Radix Kansuis, 2 parts of the Cortexs Eucommiae, 4 parts of the Radixs Astragali, 4 parts of Herba Solidaginiss, 11 parts of Radix Saposhnikoviaes, 6 parts of Semen Oroxylis, 17 parts of Rhizoma Chuanxiongs, 5 parts of the Radixs Stemonae, 13 parts of Herba Orostachyos, 7 parts of Radix Sophorae Flavescentiss, 2 parts of Cortex Moutans, 2 parts of Radix Ophiopogonis and Herba Asaris.
3. the medicament for the treatment of anthraco-silicosis according to claim 1 and 2 is characterized in that described medicament is tablet, buccal tablet, instant or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310000361.1A CN103007241B (en) | 2013-01-04 | 2013-01-04 | Medicament for treating silicosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310000361.1A CN103007241B (en) | 2013-01-04 | 2013-01-04 | Medicament for treating silicosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103007241A true CN103007241A (en) | 2013-04-03 |
| CN103007241B CN103007241B (en) | 2014-06-11 |
Family
ID=47956705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310000361.1A Expired - Fee Related CN103007241B (en) | 2013-01-04 | 2013-01-04 | Medicament for treating silicosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103007241B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362750A (en) * | 2015-11-25 | 2016-03-02 | 赵连祺 | Traditional Chinese medicine preparation for treating pulmonary silicosis and preparation method of traditional Chinese medicine preparation for treating pulmonary silicosis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1127121A (en) * | 1995-01-20 | 1996-07-24 | 杨贵森 | Xiaozhoutian (small circulation in Qigong) external curing heath care band and use method |
| CN1049597C (en) * | 1996-06-11 | 2000-02-23 | 王来运 | Liquid medicine for treatment of tracheitis and preparing method thereof |
| CN102579967A (en) * | 2011-01-14 | 2012-07-18 | 天津市中宝制药有限公司 | Traditional Chinese medicinal composition for treating lung cancer |
-
2013
- 2013-01-04 CN CN201310000361.1A patent/CN103007241B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1127121A (en) * | 1995-01-20 | 1996-07-24 | 杨贵森 | Xiaozhoutian (small circulation in Qigong) external curing heath care band and use method |
| CN1049597C (en) * | 1996-06-11 | 2000-02-23 | 王来运 | Liquid medicine for treatment of tracheitis and preparing method thereof |
| CN102579967A (en) * | 2011-01-14 | 2012-07-18 | 天津市中宝制药有限公司 | Traditional Chinese medicinal composition for treating lung cancer |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362750A (en) * | 2015-11-25 | 2016-03-02 | 赵连祺 | Traditional Chinese medicine preparation for treating pulmonary silicosis and preparation method of traditional Chinese medicine preparation for treating pulmonary silicosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103007241B (en) | 2014-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102266464B (en) | Chinese medicinal composition for treating periodontitis | |
| CN101143176A (en) | Traditional Chinese medicine for treating pneumonia | |
| CN101780167A (en) | Chinese medicine compound for preventing and curing lung diseases and clearing human body toxin and preparation method thereof | |
| CN103007241B (en) | Medicament for treating silicosis | |
| CN105616805A (en) | Traditional Chinese medicine preparation used for mastitis nursing and preparation method | |
| CN102188689A (en) | Compound combination medicament for treating COPD, preparation method and application thereof | |
| CN103142857A (en) | Chinese medicinal granules for treating bronchitis combined emphysema and preparation method thereof | |
| CN102380075A (en) | Chinese medicine for treating child respiratory system infection and inflammation | |
| CN105343344A (en) | Yin and lung nourishing formula for treating silicosis and preparation method | |
| CN102784286B (en) | Traditional Chinese medicine composition for treating infantile pneumonia | |
| CN104800570A (en) | Chinese herbal preparation for treating pneumonia | |
| CN102755607B (en) | Medicine for treating bronchitis and asthma and preparation method thereof | |
| CN100333778C (en) | Natural life beneficial Chinese medicine | |
| CN1281257C (en) | Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis | |
| CN102727614B (en) | Chinese-western medicine preparation for treating chronic obstructive pulmonary disease | |
| CN101143194A (en) | Traditional Chinese medicine for treating interstitial pneumonia | |
| CN101129856A (en) | Traditional Chinese medicine for treating lobar pneumonia | |
| CN105687684A (en) | Traditional Chinese medicine preparation for treating chronic obstructive pulmonary disease | |
| CN105582187A (en) | Traditional Chinese medicine composition formula for preventing and treating allergic dermatitis | |
| CN103784625A (en) | Traditional Chinese medicinal composition for treating chronic bronchitis | |
| CN104001031A (en) | Medicament for treating asthma | |
| CN103330822A (en) | Chinese medicine formulation for curing chronic pharyngitis | |
| CN111329952A (en) | Traditional Chinese medicine preparation special for treating infantile viral myocarditis | |
| CN113577221A (en) | A Chinese medicinal composition for treating mastitis, hyperplasia of mammary glands, breast nodule and menstrual breast pain | |
| CN108938894A (en) | A kind of proved recipe for treating chronic bronchitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140611 Termination date: 20150104 |
|
| EXPY | Termination of patent right or utility model |